Drug Trial Radar · NCT05463731
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Last checked: Nov 19, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,667
Actual
Start
Aug 1, 2022
Primary completion
Apr 24, 2024
Study completion May 12, 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Jul 19, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The reason for this study is to collect safety and efficacy information regarding the study drug remternetug in participants with early symptomatic Alzheimer's disease (AD).
Conditions
- Alzheimer's Disease
Interventions
Remternetug (IV)Drug
Administered IV
Remternetug (SC)Drug
Administered SC
PlaceboDrug
Administered IV or SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Reach Amyloid Plaque Clearance on Amyloid PET Scan for Remternetug versus PlaceboTime frame: Week 52
Locations
76 sites in 2 countries. Site status is shown where the registry gives one.
MD First Research - Chandler
Chandler, Arizona
Hope Clinical Research, Inc.
Canoga Park, California
North County Neurology Associates
Carlsbad, California
Wr- Pri, Llc
Encino, California
Neuro-Pain Medical Center
Fresno, California
Irvine Clinical Research
Irvine, California
Kaizen Brain Center
La Jolla, California
Anderson Clinical Research
Redlands, California
Mountain Neurological Research Center
Basalt, Colorado
Alpine Clinical Research Center
Boulder, Colorado
Colorado Springs Neurological Associates
Colorado Springs, Colorado
Institute for Neurodegenerative Disorders
New Haven, Connecticut
Ki Health Partners, LLc, dba New England Institute for Clinical Research
Stamford, Connecticut
JEM Research Institute
Atlantis, Florida
VIN-Julie Schwartzbard
Aventura, Florida
Brain Matters Research
Delray Beach, Florida
Neuropsychiatric Research Center of Southwest Florida
Fort Myers, Florida
Finlay Medical Research
Greenacres City, Florida
Encore Research Group- Jacksonville Center for Clinical Research
Jacksonville, Florida
ClinCloud - Maitland
Maitland, Florida
K2 Medical Research
Maitland, Florida
ClinCloud - Viera
Melbourne, Florida
Merritt Island Medical Research, LLC
Merritt Island, Florida
VIN-Andrew Lerman
Miami, Florida
Optimus U Corporation
Miami, Florida
Suncoast Clinical Research, Inc.
New Port Richey, Florida
Renstar Medical Research
Ocala, Florida
Charter Research - Winter Park
Orlando, Florida
Emerald Coast Neurology - Airport Boulevard
Pensacola, Florida
Progressive Medical Research
Port Orange, Florida
Alzheimer's Research and Treatment Center
Stuart, Florida
Brain Matters Research
Stuart, Florida
Tallahassee Neurological Clinic
Tallahassee, Florida
Charter Research - Lady Lake
The Villages, Florida
Alzheimer's Research and Treatment Center
Wellington, Florida
Palm Beach Neurology
West Palm Beach, Florida
Conquest Research
Winter Park, Florida
Columbus Memory Center, PC
Columbus, Georgia
iResearch Atlanta
Decatur, Georgia
Great Lakes Clinical Trials - Andersonville
Chicago, Illinois
Showing 40 of 76 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.